We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
-14.15%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$69.6B
AUM Growth
-$16.5B
(-19%)
Cap. Flow
-$3.3B
Cap. Flow
% of AUM
-4.75%
Top 10 Holdings %
Top 10 Hldgs %
17.71%
Holding
779
New
83
Increased
294
Reduced
313
Closed
76
Avg Time Held
10.9
quarters
Top 10 Avg Time Held
7.5
quarters
Top 20 Avg Time Held
7.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$753M |
| 2 |
Marathon Petroleum
MPC
|
+$374M |
| 3 |
Target
TGT
|
+$361M |
| 4 |
Walgreens Boots Alliance
WBA
|
+$299M |
| 5 |
Huntington Bancshares
HBAN
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANDV
Andeavor
ANDV
|
+$1.05B |
| 2 |
Merck
MRK
|
+$702M |
| 3 |
Bank of America
BAC
|
+$542M |
| 4 |
Oracle
ORCL
|
+$528M |
| 5 |
Steel Dynamics
STLD
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.74% |
| 2 | Healthcare | 14.95% |
| 3 | Industrials | 13.38% |
| 4 | Technology | 12.24% |
| 5 | Energy | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class B
BRK.B
$1.1T
| $1.64B | 2.36% |
8,030,767
-43,267
| -0.5% | -$9.04M |
2013 Q2
22 quarters
|
|
2
Johnson & Johnson
JNJ
$630B
| $1.61B | 2.32% |
12,486,839
-541,478
| -4% | -$75.5M |
2013 Q2
22 quarters
|
|
3
Cisco
CSCO
$467B
| $1.45B | 2.08% |
33,457,502
-960,736
| -3% | -$44M |
2013 Q2
22 quarters
|
|
4
Pfizer
PFE
$161B
| $1.24B | 1.78% |
29,850,436
-220,849
| -0.7% | -$9.17M |
2013 Q2
22 quarters
|
|
5
JPMorgan Chase
JPM
$885B
| $1.22B | 1.76% |
12,539,398
-3,193,863
| -20% | -$340M |
2013 Q2
22 quarters
|
|
|
6
Bank of America
BAC
$380B
| $1.14B | 1.63% |
46,087,680
-19,963,727
| -30% | -$542M |
2013 Q2
22 quarters
|
|
7
Comcast
CMCSA
$73.3B
| $1.08B | 1.56% |
31,823,642
-1,292,576
| -4% | -$47.2M |
2013 Q2
22 quarters
|
|
8
Wells Fargo
WFC
$253B
| $1.04B | 1.49% |
22,520,875
-721,376
| -3% | -$36.9M |
2013 Q2
22 quarters
|
|
9
Citigroup
C
$217B
| $1.02B | 1.46% |
19,502,094
-3,814,177
| -16% | -$242M |
2013 Q2
22 quarters
|
|
10
Verizon
VZ
$173B
| $891M | 1.28% |
15,857,072
-483,130
| -3% | -$27.4M |
2014 Q2
18 quarters
|
|
11
HP
HPQ
$27.2B
| $888M | 1.28% |
43,404,835
+2,215,865
| +5% | +$51.7M |
2015 Q1
15 quarters
|
|
12
CVS Health
CVS
$110B
| $811M | 1.17% |
12,382,737
+932,601
| +8% | +$69.6M |
2013 Q2
22 quarters
|
|
13
Microsoft
MSFT
$3.97T
| $800M | 1.15% |
7,881,016
+14,149
| +0.2% | +$1.52M |
2013 Q2
22 quarters
|
|
14
Allstate
ALL
$58B
| $784M | 1.13% |
9,485,145
-1,783,509
| -16% | -$160M |
2013 Q3
21 quarters
|
|
15
Chevron
CVX
$416B
| $780M | 1.12% |
7,170,863
-92,061
| -1% | -$10.7M |
2016 Q3
9 quarters
|
|
|
16
Procter & Gamble
PG
$351B
| $775M | 1.11% |
+8,428,522
| New | +$753M |
2018 Q4
0 quarters
|
|
17
Chubb
CB
$132B
| $752M | 1.08% |
5,823,366
+520,391
| +10% | +$67.2M |
2013 Q2
22 quarters
|
|
18
DELISTED
Discover Financial Services
DFS
| $733M | 1.05% |
12,420,880
-255,588
| -2% | -$17.6M |
2013 Q2
22 quarters
|
|
|
19
Marathon Petroleum
MPC
$128B
| $718M | 1.03% |
12,173,365
+5,479,818
| +82% | +$374M |
2013 Q2
22 quarters
|
|
20
RTX Corp
RTX
$251B
| $707M | 1.02% |
10,545,419
+34,093
| +0.3% | +$2.68M |
2013 Q2
22 quarters
|
|
21
Elevance Health
ELV
$89.5B
| $701M | 1.01% |
2,669,935
-15,482
| -0.6% | -$4.26M |
2013 Q2
22 quarters
|
|
22
Cigna
CI
$74.6B
| $690M | 0.99% |
3,633,997
+289,480
| +9% | +$60.4M |
2015 Q1
15 quarters
|
|
23
Medtronic
MDT
$113B
| $671M | 0.96% |
7,377,001
+734,286
| +11% | +$68.6M |
2013 Q2
22 quarters
|
|
24
Boeing
BA
$150B
| $629M | 0.9% |
1,951,632
+123,895
| +7% | +$42.8M |
2018 Q2
2 quarters
|
|
25
KeyCorp
KEY
$21.3B
| $610M | 0.88% |
41,244,050
+10,713,851
| +35% | +$189M |
2017 Q3
5 quarters
|
|
Similar funds
Boston Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Boston Partners held 779 positions worth $69.6B, down 19% from $86.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Partners withdrew a net $3.3B in Q4 2018, closing 76 positions and reducing 313 holdings. Its most notable exit was Andeavor, an estimated $1.05B position sold in full.
By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Boston Partners opened a new position in Procter & Gamble worth $775M.
- Boston Partners's largest Q4 2018 buy was Procter & Gamble: 8,428,522 shares worth $775M.
- Boston Partners added most to Marathon Petroleum in Q4 2018, an estimated $374M increase.
- Boston Partners's biggest Q4 2018 reduction was Merck, cutting an estimated $702M.
- Boston Partners fully exited Andeavor in Q4 2018, selling an estimated $1.05B.
- Boston Partners's ten largest holdings make up 18% of its $69.6B portfolio in Q4 2018.
- Boston Partners opened 83 new positions and closed 76 in Q4 2018.
- Boston Partners's portfolio value fell 19% quarter-over-quarter to $69.6B.
Based on Boston Partners's 13F filing for Q4 2018, filed 7 Feb 2019.